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Cell surface aminopeptidase A and N activities in human glomerular
epithelial cells. Cell surface aminopeptidases N (APN) and A (APA)
have been characterized on cultured human glomerular epithelial cells
and a SV4O-transformed cell line derived from them. APN had a wide
substrate specificity whereas APA only attacked peptides with an acidic
N terminal amino acid. Both enzymes also differed by their sensitivity
to divalent cations and to aminopeptidase inhibitors. Phorbolmyristate
acetate (PMA) stimulated APN but not APA expression after a lag time
of 12 hours. An increase of twice the basal value was observed with 10
ng . m1' PMA. This effect was confirmed by immunofluorescence
staining using a specific anti-APN monoclonal antibody. Both ecto- and
total enzyme activities were stimulated by PMA. The effect of PMA
was suppressed by H7, a PKC inhibitor, and cycloheximide, an
inhibitor of protein synthesis. Thrombin (I to 2.5 U . ml') and inter-
feron (IFN)-y (100 U m1 ') also stimulated APN activity, the latter
after longer exposure of the cells. APA activity was increased by
8-bromo-cAMP and two cAMP-stimulating agents, forskolin and isobu-
tylmethylxanthine (IBMX). A twofold increase above basal value was
obtained with 100 /LM forskolin after 72 hours of treatment. cAMP-
stimulated APA activity was suppressed by cycloheximide. Dexam-
ethasone also stimulated APA activity. The effects of forskolin and
dexamethasone were additive. These results demonstrate that APN and
APA in glomerular epithelial cells are under different regulations:
mitogens and IFN-yfor APN, cAMP and glucocorticoids for APA. This
selective expression may imply possible functional consequences in
glomerular diseases.
Cell surface peptidases play an important role in signal
transduction and communication between cells. Aminopepti-
dases have recently attracted much interest and four different
types of these enzymes, A, N, P and W, have been described
[1]. Aminopeptidase N (APN; a-aminoacylpeptide hydrolase,
EC 3.4.11.2) acts with a relatively broad substrate specificity on
peptides with an N-terminal neutral amino acid. The complete
amino acid sequences of human intestinal and rat kidney APN
have been deduced from the corresponding cloned cDNA [2, 3].
Sequence comparisons showed that APN was identical to CD
13 (gp 150), a cell surface glycoprotein originally identified on
subsets of normal and malignant human myeloid cells [4]. APN
is widely distributed with the highest density in the renal cortex
and intestinal microvilli [51. Histochemical studies failed to
detect any APN activity in human and murine glomeruli, in
contrast with a high activity in the brush border of proximal
tubules [6, 7]. However, using more sensitive immunocyto-
chemical techniques, APN was found to be expressed both in
glomeruli and proximal tubules on mouse renal sections [8].
Aminopeptidase A or angiotensinase A (APA; L-a-aspartyl or
L-a-glutamylpeptide hydrolase, EC 3.4.11.7) acts on peptides
with an N-terminal acidic amino acid. In particular, it splits off
N-terminal aspartic acid from angiotensin II (Ang II), reducing
markedly the activity of this hormone. APA is identical to the
murine B-cell differentiation antigen, BP-1/6C3, which is ex-
pressed on immature B-lineage cells [9]. High APA activity has
been found in human and rat glomeruli, particularly in the
podocytes [6, 10]. There is also a positive APA reaction in the
brush border of the proximal tubule [6, 7].
Efforts to relate the structure of previously-described cell
surface antigens to that of aminopeptidases have allowed the
functions of these enzymes to be better appreciated. It has been
shown that mouse thymocyte-activating molecule (THAM) was
associated with APN and that a monoclonal antibody to this
developmentally regulated T cell antigen-activated mouse T
lymphocytes [8, 11]. Moreover, interleukin-7 (IL-7) preferen-
tially induced BP-l/6C3 (APA) expression on pre-B cells to-
gether with their proliferation [12]. Both findings reinforce the
hypothesis of a role for APN and APA in signal transduction.
The aim of the present study was to characterize APN and
APA in cultured human glomerular epithelial cells and to study
the regulation of their expression in response to mitogens,
cytokines, cyclic nucleotides and hormones. Evidence is pro-
vided that human glomerular epithelial cells normally possess at
their surface both aminopeptidases. Interestingly, control of
their expression is different. APN is sensitive to mitogens and
interferon (IFN)-ywhereas APA is sensitive to cyclic adenosine
monophosphate (cAMP) and glucocorticoids.
Methods
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Materials were obtained from the following suppliers: Dul-
becco's modified Eagles medium (DMEM), Ham's F-12 me-
dium, RPMI 1640 medium and 0.05% trypsin-0.02% EDTA
from Flow Laboratories (Irvine, Ayrshire, UK); fetal calf
serum (FCS), penicillin G and streptomycin sulphate from
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Gibco (Grand Island, New York, USA); anti-myosin and anti-
urokinase antisera from Miles (Paris, France); L-glutamyl p-ni-
troaniide from Serva (Heidelberg, Germany); L-amino acid
p-nitroanilide substrates of aminopeptidase N, amastatin, be-
statin, 1, 10-phenanthroline, E. coil 026 B6 lipopolysaccharide,
collagenase, 8-bromo-cyclic AMP, 8-bromo-cyclic GMP, cal-
cium ionophore A23 187, phorbol- 12-myristate- 13-acetate
(PMA), actinomycin D, cycloheximide and HEPES from Sigma
(St. Louis, Missouri, USA); angiotensin II (Hypertensin) from
Ciba-Geigy (Basel, Switzerland); human recombinant interleu-
kin (IL)-1/3, tumor necrosis factor (TNF)-a and interferon
(IFN)-y from Genzyme corporation (Cambridge, Massachu-
setts, USA); thiorphan from Bioprojet (Paris, France); 1(5-
isoquinolinylsulfonyl)-2-methylpiperazine (H7) from Seikagaku
(Tokyo, Japan). Anti-von Willebrand factor, a pool of mono-
clonal antibodies allowing this high molecular mass protein to
be adequately detected, was a gift from Pr. D. Meyer (Paris,
France). All other chemicals were of reagent grade and were
used without further purification. Stock solutions of PMA in
dimethylsuiphoxide (DMSO) were prepared (1 mg m1 ')and
were kept at —20°C. Plastic flasks and dishes were obtained
from Nunc (Roskilde, Danemark).
Cell culture
Human glomerular epithelial cells were prepared as previ-
ously described [131. Renal cortical tissue was obtained from
human cadaver kidneys judged to be unsuitable for transplan-
tation. Glorneruli were isolated by successive passages through
different sieves. Human glomerular epithelial cells were ob-
tained by collagenase digestion of isolated glomeruli. These
cells were cultured in RPM! 1640 medium buffered with 20 mivi
HEPES to pH 7.4 and supplemented with 2 m glutamine, 10%
fetal calf serum, 100 U . ml' penicillin and 100 j.tg ml
streptomycin. They were maintained at 37°C under a humidified
atmosphere of 5% C02/95% air. Human glomerular epithelial
cells reached confluence after 10 to 15 days. They were subcul-
tured and studied after one to three passages. Human glomer-
ular epithelial cells were identified by immunofluorescence
techniques. Staining was positive with antisera directed against
urokinase and neutral endopeptidase, respectively. No staining
was obtained with anti-myosin and anti-von Willebrand factor
antisera.
Most studies were also carried out on a SV4O-transformed
human podocyte cell line that derives from a primary culture of
podocytes obtained from a pure preparation of unencapsulated
glomeruli which has been transfected with a replication-defec-
tive SV-40 plasmid [14]. The resulting cell line after 12 passages
was grown in a hormonally-defined medium [DMEM-Ham's
Fl2 1:1 (vol/vol); glutamine, 2 mM; sodium selenate, 30 nM;
transferin, 5 jsg. m1'; insulin, 5 g. ml; dexamethasone, 50
nM; HEPES, 20 m, pIT 7.4] containing 2% fetal calf serum.
Clone A4 used in this study exhibits the major characteristics of
podocytes, including expression of vimentin, podocalyxin, neu-
tral endopeptidase, heparan sulfate proteoglycans, and produc-
tion of type IV collagen [14].
Immunofluorescence studies
Expression of APN was detected using a specific monoclonal
antibody (code number 312 A 27) raised in the laboratory [151.
For demonstrating cell surface APN, cells were fixed in 4%
paraformaldehyde during 15 minutes at room temperature.
Other cells were treated with methanol to allow the antibody to
penetrate the cells. Cells were then washed three times succes-
sively in 0.1 M glycine and phosphate-buffered saline. APN was
demonstrated after incubation with 100 g mY' anti-APN
antibody for 30 minutes at room temperature followed by a
second incubation with fluorescent anti-mouse IgG also during
30 minutes, and by three washings in phosphate-buffered saline.
Parallel studies could not be performed for APA detection due
to the lack of specific antibody against human APA.
Enzyme activities
Cell surface APN activity was determined on confluent
monolayers. This technique compared with the study of cell
suspensions might underestimate the total ectoenzyme activity
since only a part of the cells can gain contact with the substrate.
It has, however, the advantage of being able to study cells at
rest maintained under more physiological conditions. Cells in
24-well plates were rinsed three times and incubated at 37°C in
calcium-free phosphate-buffered saline, pH 7,4, supplemented
with 1 mi MgCl2. In some experiments, 50 mri HEPES buffer,
pH 7.4, containing 130 mt NaCl and 1 m MgC12 was used.
Enzyme activity was determined under zero-order kinetic con-
ditions, using 1.5 m alanine p-nitroanilide as a substrate unless
otherwise indicated. After an incubation of 5 to 20 minutes at
37°C, the amount of p-nitroanilide formed was measured in the
supernatant. It was determined from a standard curve by
reading at an OD of 405 nm using a Perkin-Elmer double beam
spectrophotometer. Cell-free and substrate-free blanks were
run in parallel.
Cell surface APA activity was determined from the hydroly-
sis of 10 mi -glutamyl-p-nitroanilide over 10 to 30 minutes by
cells incubated in 50 mrvi Tris-HCI buffer, pH 8.0, containing
130 mM NaCl and 10 mM CaCl2.
Total enzyme activities for both enzymes were measured in
cells which had been sonicated using a Branson sonifier (model
W 185 D, Branson Sonic Power Co, Danbury, Connecticut
USA) at position 3. The tube containing the cells was immersed
in an ice-water bath and the sample was sonicated for 60
seconds.
Enzyme activities were expressed as nmol p-nitroanilide
formed per minute and per mg of cell protein.
Km and V, determinations
Initial reaction velocities (V) were determined over substrate
concentration (S) ranges of 0.1 to 5 mivi and 0.25 to 10 m for
APN and APA, respectively, Data were plotted according to
Hofstee (V vs. V/S) to determine the Km and Vmax values [16].
Cell protein
After appropriate digestion with I M NaOH, cell protein was
determined by the method of Lowry et al [17] using bovine
serum albumin as the standard.
Statistical analysis
Results are expressed as means SE. Comparisons between
groups were made using Student's t-test for unpaired values and
analysis of variance. Correlations between two parameters
were estimated by regression analysis,
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Fig. 1. Expression of aminopeptidase N in human glomerular epithelial cells. The enzyme was detected by immunofluorescence using a specific
monoclonal antibody. Cells were fixed with 4% paraformaldehyde before incubation with the antibody under control conditions (A) or after
exposure to lOng ml PMA for 48 hours (B). Phase contrast micrographs of the same fields are also shown (C, D). Films for immunofluorescence
pictures (ILFORD HP5 plus, 400 ASA) were exposed for 18 seconds to the illuminated microscope field and the resulting negatives were printed
under the same conditions. Note increased intensity of fluorescence in PMA-treated cells (B).
Results
Cell surface location of APA and APN
Human glomerular epithelial cells were found to hydrolyze
substrates of both APA and APN. Enzyme activity was deter-
mined with intact cells. Cell viability measured by the trypan
blue exclusion method was preserved during the incubation
time. The proportion of intact cells exceeded 97% after enzyme
determination and was not different from that found in control
preparations. The following is taken as evidence that both
enzyme activities were present at the cell surface: (1) Sub-
strates were hydrolyzed by intact cultured cells and their
respective products were released in the extracellular medium;
(2) The amount of substrate hydrolyzed over 5 to 30 minutes
was linearly related to time, making it unlikely that a significant
fraction of substrate had been hydrolyzed after entering the
cells; (3) Immunofiuorescence studies after fixation with para-
formaldehyde, a fixative that only exposes antigens expressed
at the cell surface, showed a marked staining with a monoclonal
anti-APN antibody (Fig. 1). Methanol pretreatment of the cells
increased the staining of epithelial cells obtained with this
anti-APN antibody; (4) APA and APN activities were absent in
the incubation and the culture medium, indicating that the
enzymes were not released from the cells. Substantial portions
of enzyme activities were expressed at the cell surface of
epitbelial cells with some variability according to the prepara-
tion (1.17 0.06 — 3.74 0.17 nmol. min . mg' fr APA
and 1.42 0.09—3.16 0.22 nmol. min1 . mg forAPN).
Total enzyme activities measured in sonicated cells were
greater (2.47 0.10 — 5.92 0.15 nmol . min . mg1 for
APA and 2.50 0.11 — 6.51 0.37 nmol. mm_i . mg_i for
APN) showing that both enzymes were also present within the
cells.
Characteristics of APA and APN
APN was shown to have a wide substrate specificity (Table
1). Substrates were hydrolyzed in the following order of reac-
tivity: alanine p-nitroanilide > leucine p-nitroanilide > lysine
p-nitroanilide > arginine p-nitroanilide > glycine and valine
p-nitroanilide. APA activity was only studied with glutamic
acid-a-p-nitroanilide.
The pH versus activity profile of human glomerular epithelial
cell APN was studied with two different buffers: phosphate-
buffered saline and HEPES buffer. The optimal pH was 7.4 with
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Table 1. Substrate specificity o
glomerular
f surface aminopeptidases in human
epithelial cells
Substrate
Amniopeptidase activity
nmol mg' min"
Alanine p-NA
Leucine p-NA
Lysine p-NA
Arginine p-NA
Glycine p-NA
Valine p-NA
Glutamic acid p-NA
2.51 0.06
2.17 0.11
1,06 0.05
0.76 0.02
0.21 0.01
0.19 0.005
2.27 0.12
Table 2. Effect of divalent cations on surface aminopeptidase N
(APN) and A (APA) activities of human glomerular epithelial cells
APN APADivalent
cation nmol• mi,F' . mg'
None 2.95 0.08 0.94 0.03
EDTA, 5 mrsi 2.52 0.04 0.4! 0.02
Ca2, 1 m 3.29 0.12 1.21 0.08
Ba2, 1 miss 3.22 0.39 1.20 0.04
Mg2t 1 mist 2.97 0.27 0.90 0.05
Mn2, 1 mM 2.56 0.22 1.14 0.06
HEPES. It ranged between 7.4 and 8.0 in phosphate-buffered
saline. APA activity was determined in 50 miss Tris-buffer. An
optimal pH was observed at 7.8 to 8.4. An identical pH profile
with SV-40 transformed human epithelial cells was demon-
strated for both APN and APA activities.
The effect of divalent cations on surface APA and APN
activities is presented in Table 2. Quite similar APA activities
were obtained with calcium, barium and manganese at 1 mM
concentration. Activity was lower in the presence of 1 miss
magnesium and was markedly inhibited by 5 miss EDTA. APN
activity was apparently the same in the presence of 1 mist
calcium, barium or magnesium. The substantial residual activ-
ity of APN found in the absence of divalent cations, or in the
presence of 5 misi EDTA is probably due to the presence of zinc
normally bound to the residues participating in the catalytic
reaction [3].
Kinetic studies were performed with L-glutamic acid-a-p-
nitroanilide (0.25 to 10 mM) for APA activity, and with L-ala-
nine p-nitroanilide (0.1 to 5 mM) for APN activity. The data
were transformed according to Hofstee. Regression analysis
provided apparent Km and values of 0.48 miss and 3.82
nmol . min" . mg"', respectively, for APA and of 0.70 mrsi and
4.4 nmol . min1 . mg, respectively, for APN. With SV-40
transformed epithelial cells apparent Km and Vmax values of
0.29 miss and 1.52 nmol. min' mg', respectively, for APA
and of 1.01 m and 2.10 nmol. min' . mg', respectively, for
APN were obtained. APA activity was inhibited by 43.1% with
1 mM angiotensin II (Hypertensin). This effect was observed
keeping substrate concentration of glutamyl p-nitroanalide at
1.5 mtc. Inhibition of APA activity was also observed with
C02 60'
.0
-cC
e 40'
Fig. 2. Comparative effects of three different inhibitors on surface
aminopeptidase A and N activities in human glomerular epithelial cells.
Percent of inhibition is shown as mean sa of 4 determinations. Data
were analyzed using Student's t-test. Activities of both enzymes were
significantly reduced (P < 0.01) in comparison with control after
exposure to each of the inhibitors studied. Control values were 1.88
0.loandl.26±0.O6nmol .misc'. mg"foraminopeptidasesNandA,
respectively.
acidic amino acids. Aspartic and glutamic acid (10 miss) inhib-
ited APA activity by 20.2% and 15.2%, respectively.
Effect of aminopeptidase inhibitors
Three known inhibitors of aminopeptidases, amastatin, be-
statin and 1, 10-phenanthroline were used (Fig. 2). 1, 10-phenan-
throline, a chelating agent, was the least potent inhibitor. Used
at a concentration of 1 mist, it had approximately the same
inhibitory effect on APA (78.6%) and APN (71.3%) activities.
Amastatin (30 sM) produced a significantly higher inhibition of
APA (82.5%) than of APN (60%). In contrast, bestatin (100 tM)
was more inhibitory for APN (64.9%) than for APA (39.7%).
Induction of surface aminopeptidases
Effect of phorbolmyristate acetate (PMA), thrombin and
cytokines. Glomerular epithelial cells were treated for 48 hours
with A 23187 calcium ionophore (1 p.M), IL-l/3 (25 U .
TNFa (25 ng ml I), E. coli lipopolysacchas-ide (10 jzg. m1 I)
and PMA (10 ng . ml'), a tumor promoter and maturation-
inducing agent (Table 3). There was a statistically significant
increase in APN activity with IL-lfl (P < 0.01), LPS (P < 0.01)
and PMA (P < 0.001). Since IL-l/3 could have been degraded
during the period of incubation due to the presence of neutral
endopeptidase (enkephalinase, EC 3.4.24.11) at the surface of
glomerular epithelial cells [18], parallel experiments were per-
formed in the presence of thiorphan (10 MM), an inhibitor of
neutral endopeptidase. The increase in APN activity above
basal value after treatment of the cells by 25 U . ml"1 IL- lfl was
similar with (3.70 0.57 nmol . misc' . mg 1) and without
(3.55 0.27 nmol. min'' . mg'; P > 0.05) thiorphan. Com-
bined treatments by PMA and IL-1f3, or PMA and LPS pro-
duced additive increases of APN activity. TNFa was without
effect on APN activity at the concentration tested. APA activity
100
80
Cells were incubated for 20 minutes with 1 m of substrate. Values
are means 5E of 4 determinations, 20
0
Amastatin Bestatin Phenanthroline
30p.M 100.M l000p.W
Cells were incubated for 20 minutes in 50mM HEPES buffer, pH 7.4,
for aminopeptidase N or for 30 minutes in 50 miss Tris-HCI buffer, pH
8.0 for aminopeptidase A with EDTA or the divalent cation selected.
Values are means 5E of 4 determinations.
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Table 3. Effect of various agents on human glomerular epithelial cell
aminopeptidases A (APA) and N (APN)
Agent
APN APA
nmol. min' mg1
None
A 23187 Ca2 ionophore, 1 tM
IFN-y, 100 U. m1'
PMA, 10 ng. ml'
TNFa, 25 ng . m1'
PMA, 10 ng. m1' + TNFa,
25 ng m1'
IL-1f3, 25 U . ml'
PMA, 10 ng. m1' + IL-113,
25 U . ml'
LPS, 10 j.tg . m1'
PMA, 10 ng . m1' + LPS, 10
sg.ml'
2,84 0.05
2.34 0.03
3.09 0.08
4.69 0.10"
2.89 0.05
4.71 0,21b
3.20 0.12a
5.70 0,17b
3.38 0.05a
5.30 0,04b
0.85 0.03
0.92 0.06
0.82 0.04
0.76 0.02
0.82 0.02
0.76 0.01
0.80 0.02
0.80 0.06
0.91 0.07
0.86 0.05
Cells were cultured with agents in the concentrations stated for 48
hours. Values are means SE of 4 to 10 determinations. Data were
analyzed using Student's f-test or two way analysis of variance when
combined effects were studied. The effects of LPS and IL-1f3 were
additive to those of PMA (no significant interaction).
a P < 0.01 and b P < 0.001 vs. control
PMA, ng m1'
Fig. 3. Aminopeptidase N (closed circles) and aminopeptidase A (open
circles) activities plotted against phorbolmyristate acetate (PMA) con-
centration. Human glomerular epithelial cells were cultured with PMA
for 48 hours. Means SE of 4 determinations are shown. Data were
analyzed using Student's f-test. Aminopeptidase N activity at any
concentration of PMA studied was significantly greater than control (P
<0.01). There was no significant change of aminopeptidase A activity.
Table 4. Effect of protein kinase C and protein synthesis inhibition
on PMA-induced aminopeptidase N of human glomerular epithelial
cells
Agent
Aminopeptidase N activity
nmol. min' . mg'
Control 1.93 0.12
PMA, 10 ng . ml' 3.15 0.2T
H7,50M 2.12±0.15
PMA, lOng. mY' + H7, 50 M 2.04 0.19
Cycloheximide, 0.5 g m1' 2.08 0.07
PMA, 10 ng. ml' + cycloheximide, 2.15 0.02
0.5 Lg. m1'
Cultured epithelial cells were pretreated for 1 hour with H7 or
cycloheximide and then incubated with PMA, 10 ng. m1'. Values are
means SE of 4 determinations. Data were analyzed using Student's
f-test.
a P < 0.001 vs. control
1
'a,-
'a'
CE
6-
5-
4.
3-
2-
1-
0-
min' . mg' for the ectoenzyme, 6.46 0.11 and 3.62 0.06
nmol . min' . mg' for the total enzyme with and without
PMA (10 ng. ml'), respectively (P < 0.01). The stimulatory
effect of PMA on APN expression at the surface of glomerular
epithelial cells was confirmed by immunofluorescence. Staining
in the presence of an anti-APN monoclonal antibody was more
marked after exposure of the cells to 10 ng. ml PMA for 48
hours than under control conditions (Fig. 1). To verify whether
the effect of PMA was mediated by protein kinase C (PKC) and
0 5 10 15
whether it required a new protein synthesis, human glomerular
epithelial cells in culture were pretreated with H7, an inhibitor
of PKC, or with cycloheximide, an inhibitor of protein synthe-
sis (Table 4). When added to human glomerular epithelial cells
one hour before PMA, H7 prevented APN induction by PMA.
In addition, PMA did not induce APN activity of cyclohexi-
mide-pretreated epithelial cells.
The fact that stimulation of PKC was necessary for the
increased expression of APN led us to study the effect of
endogenous activators of PKC. We chose to study thrombin,
which is a mitogen for glomerular cells acting via the phospho-
20 25 lipase C pathway [19]. Cells were exposed to thrombin in the
concentration range of 0.1 to 2.5 U . m11 for 48 hours. There
was a dose-dependent increase of surface APN activity. Values
of 4.23 0.06,4.93 0.17 and 5.58 0.08 nmol. min1 .mg
were observed under basal conditions and in the presence of 1
and 2.5 U . ml1 thrombin, respectively, the latter two repre-
senting 116.5 (P < 0.05) and 132% (P < 0.001) increases of basal
value.
Although no stimulatory effect on APA and APN activities
had been obtained after 48 hours of incubation with IFN-y, we
thought it of interest to study this cytokine over longer periods
of incubation since its role in cell differentiation has been
demonstrated in other preparations [20]. Cells were cultured
with IFN-y (100 U. ml1) for up to 11 days. Surface APN
activity increased markedly with time. A statistically significant
increase was observed from day 5 (P < 0.05) with a maximum
increase at day 11 (2 18% above basal value; Fig. 4). APN
activity in response to IFN-y was more stimulated in prolifer-
ating than in confluent epithelial cells (data not presented). In
contrast, IFN-y had no significant effect on APA activity.
was not changed by any of these products. We more thoroughly
studied the effect of PMA since this agent was the most potent
on APN of those used. Stimulation by PMA was apparent only
after 12 hours of incubation and reached a maximum at 48 to 72
hours. The dose-response curve at 48 hours is shown in Figure
3. PMA at 1 ng. m1' produced a significant increase of APN
activity. The maximal effect was obtained at 10 ng. ml1 (16
nM). PMA stimulated both surface and total APN activities.
APN activity was 5.92 0.56 and 2.85 0.07 nmol.
Time, days
Fig. 4. Effect of IFN--y on the expression of aminopeptidase N activity
in glomerular epithelial cells. Cells were cultured with JFN-y (100
U mr') for up to 11 days. Values are means SE of 4 determinations
expressed as % of basal activity. Data were analyzed using Student's
t-test. Aminopeptidase N activity was significantly greater than control
(P < 0.01) from the fifth day of incubation.
Effect of cyclic nucleotides. Epithelial cell aminopeptidase
activity was also modulated by cAMP. Parental and trans-
formed human glomerular epithelial cells were cultured for 72
hours with 8-bromo-cAMP, IBMX, an inhibitor of phosphodi-
esterase, or forskolin, a diterpene which activates the catalytic
moiety of adenylate cyclase. 8-bromo-cAMP produced a dose-
dependent and significant increase in APA activity in both
normal and transformed epithelial cells. Values 68 and 85%
above control were found in the presence of 500 LM 8-bromo-
cAMP for these two preparations, respectively (Fig. SA). In
contrast, the increase in APN activity was relatively small,
reaching only values 11.8 and 14.2% above control under the
same conditions. Treatment of epithelial cells by IBMX pro-
duced also a marked increase in APA activity (58 and 65%
increases in parental and transformed cells, respectively) and a
small increase not exceeding 10% in APN activity (Fig. SB).
The highest increase in APA activity occurred in the presence
of forskolin. Treatment by this drug stimulated APA activity in
a dose-dependent manner. After a 72 hour treatment by 100 LtM
forskolin, surface APA increased by 140 and 200% in normal
Discussion
The present study demonstrates that intact human glomerular
epithelial cells in culture hydrolyze synthetic substrates of APA
and APN. If the presence of APA in the human podocytes has
already been shown, that of APN was unexpected, this enzyme
being essentially localized in the human kidney in the brush
border of the proximal tubule [6, 10]. We have also recently
shown that APN was expressed on human cultured mesangial
cells [22]. Whereas substrate specificity is relatively broad for
APN suggesting that it can attack a variety of peptides, APA
hydrolyzes only peptides with an acidic N terminal residue such
as aspartic acid. This is the case of angiotensin II which can be
considered as a preferential substrate of the enzyme. We have
only studied APA and APN present at the cell surface since we
measured enzyme activities on intact cells in monolayer. How-
ever, both enzymes are also present in the cytosol of
podocytes, as shown by the greater activity per mg of protein
found in sonicated cells. The properties of APA and APN that
we described in glomerular epithelial cells are close to those
previously reported in other preparations. Rat renal APA
exhibited a Km of 0.23 mivt, and its activity was competitively
inhibited by angiotensin 11123]. APA activity in human cultured
endothelial cells and in human placental microvilli was inhibited
by phenanthroline [24, 25] and stimulated by calcium chloride
[25]. Surface APN exhibited Km of 0.40 and 0.86 m in human
lymphocytes [26] and human mesangial cells [22], respectively,
and its activity was inhibited in both preparations by bestatin,
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and transformed epithelial cells, respectively (Fig. SC). At this
same concentration, forskolin markedly inhibited epithelial cell
proliferation (17.8 0.4 vs. 24.6 2.1 gg cell protein per well)
indicating that the increase in enzyme activity was not due to a
mitogen effect. APA activity in the presence of 10 jiM forskolln
was still significantly increased, reaching values 81.3 and 116%
above control in normal and transformed cells, respectively.
Increases in APN activity under the same conditions did not
200 - exceed 16.7 and 22.5% above basal value. Forskolin stimulated
both surface and total APA activities (data not presented).
Forskolin-dependent increase in APA activity could be pre-
vented by pretreatment with either actinomycin D, an inhibitor
of RNA synthesis, or cycloheximide, an inhibitor of protein
Z synthesis (Table 5). In contrast with cAMP and cAMP-stimu-
lating agents, treatment of human glomerular epithelial cells by
8-bromo-cOMP (500 jiM) for 72 hours had no significant effect
a. on APA and APN activities.
a We recently demonstrated that treatment of human glomer-
.E 100• ular epithelial cells by dexamethasone increased ecto-APA
activity in a dose- and time-dependent manner [21]. Therefore
we felt it of interest to study the combined effects of dexam-
ethasone (0.5 jiM) and forskolin (10 jiM) or 8-bromo-cAMP (500
jiM). Surface APA activity was induced significantly by each of
these agents studied alone. Dexamethasone and forskolin had
additive effects whereas 8-bromo-cAMP potentiated the effect
of dexamethasone (Fig. 6). There were small increases in APN
activity after a 72 hour treatment by dexamethasone and
8-bromo-cAMP. Both agents in combination had an additive
effect. Indeed, APN activity increased by 25.5% after dexa-
0 2 5 8 11 methasone (0.5 jiM), 14.4% after 8-bromo-cAMP (500 jiM) and35% with both agents.
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Fig. 5. Effect of 8-bromo-cAMP (A), IBMX (B) and forskolin (C) on
aminopeptidase A (APA; solid line) and aminopeptidase N (APN;
interrupted line) of normal (open symbols) and transformed (closed
symbols) glomerular epithelial cells. Cells were cultured with the
agents indicated for 72 hours. Enzyme activity is given as percent of
increase above basal value after treatment. Values are means SE of
4 determinations. Basal values were 1.98 0.07 and 2.40 0.08
nmol . min' mg' for APA and APN, respectively in parental
glomerular epithelial cells, and 0.34 0.01 and 1.74 0.05
ninol min mg' for APA and APN, respectively, in transformed
glomerular epithelial cells. Data were analyzed using regression100 analysis. Aminopeptidase A and N activities were significantly
correlated with the concentration of the agent tested (P < 0.001 and
P < 0.05 for each enzyme, respectively).
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Treatment
Aminopeptidase A activity
nmol min' mg'
Control 1.28 0.08
Forskolin, 10 MM 2.41 0.28
Cycloheximide, 0.1 j.tg mF' 1.04 0.05
Forskolin, 10 MM + 1.12 0.03
cycloheximide, 0.1 gg mL'
Actinomycin D, 0.1 pg m1 1.10 0.05
Forskolin, 10 jig + actinomycin D, 1.34 0.04
0.1 jig/ml'
phenanthroline and amastatin [22, 26]. Its Km in a rat kidney
homogenate was 0.24 mivi [23].
Surface aminopeptidase A and N activities of human glomer-
ular epithelial cells were found to be under different regulations.
PMA, a tumor-promoting phorbol ester, IL-i and IFN-y were
only active on APN, whereas cAMP, whatever the reason for
its accumulation, and dexamethasone, a glucocorticoid hor-
mone, stimulated mainly the activity of APA. The stimulation
of APA and APN activities by these different mediators was not
the result of their effect on cell growth since the amount of
protein per well was either diminished in the case of forskolin or
unchanged in the other cases. We previously reported a similar
stimulatory effect of PMA on APN of human mesangial cells
[221. The initial step of PMA mode of action is the activation of
PKC which results in the induction of c-fos and c-jun. Both
compounds interact with a specific DNA element termed AP-1
binding site, resulting in gene transcription and protein synthe-
sis [271. Such a mechanism may explain the stimulatory effect of
PMA on APN expression since 117, an inhibitor of PKC, and
cycloheximide, an inhibitor of protein synthesis, were both
suppressive. Moreover, APN stimulation by PMA required a
lag time of 12 to 24 hours. Similar effects of phorbolesters on the
expression of cell surface proteins have already been reported,
For example, tetradecanoyl phorbol acetate (TPA) induced the
FcR II type of IgG receptors which is involved in monocytc
cytotoxicity and phagocytosis of IgU-coated particles [28].
Phorbolesters also increased the production of enzymes in-
volved in angiogenesis and tumor extension such as collage-
nase, plasminogen activator and urokinase [29, 30]. IFN-y is
considered to be an important regulating factor in a variety of
cells including macrophages, lymphocytes, tumor cells and
fibroblasts. It induces the appearance of new surface markers or
receptors such as class II MHC antigens and Fc receptors for
monomeric IgO (FcR 1) [201. It also induces cells to express
ectoenzymes such as 5'-nucleotidase and adenosine deaminase
on monocytes and functional activities characteristic of cells
differentiating along the monocytic pathway [31]. We demon-
strate in the present study that glomerular epithelial cells may
also be the target of IFN-y. This cytokine could alter the
phenotype of these cells in a similar manner to PMA as shown
by the increased activity of cell surface aminopeptidase N. The
Fig. 6. Effect of 0.5 psi dexamethasone (Dcx), 10 jiM forskolin (FK)
and 500 — 8-bromo-cAMP on aminopeptidase A (APA) activity of
human glomerular epithelial cells. Cells were cultured with the agents
indicated for 72 hours. Enzyme activity is given as percent of basal
value after treatment. Values are means SE of 4 determinations. Data
were analyzed using Student's t-test or two-way analysis of variance
when combined effects were studied. The increase of APA activity after
dexamethasone, forskolin or cAMP treatment was significant vs. con-
trol (P c 0.001). The effect of forskolin was additive to that of
dexamethasone (no significant interaction). The effect of cAMP plus
dexamethasone exceeded the sum of activities obtained with each of
these agents separately (significant interaction, P < 0.025).
same differentiating effect of PMA and IFN-y has already been
observed for 5' nucleotidase in monocytes [31] and Fey recep-
tors in a human monoblast cell line [27].
Regulation of APA activity was found to be different from
that of APN. We demonstrated previously that dexamethasone
increased ecto-APA activity of human glomerular epithelial
cells in a dose- and time-dependent manner. Maximum increase
of APA activity occurred after treatment by 0.5 jiM dexametha-
sone for five days. Actinomycin D and cycloheximide pre-
vented and RU 38486, a glucocorticoid receptor antagonist,
suppressed the dexamethasone-induced increase in APA activ-
ity [21]. The stimulatory effect of dexamethasone on cell
surface APA activity was confirmed in the present study with
an increase of twice basal value after 72 hour exposure to 0.5
jiM dexamethasone. In addition to dexamethasone, we found
that APA activity was markedly stimulated by cAMP. The most
marked increase was observed with forskolin, an ubiquitous
stimulator of the catalytic moiety of adenylate cyclase.
8-bromo-cyclic AMP, a cell penetrating analogue of cAMP, also
stimulated basal APA activity by 85%. The effect of JBMX, a
phosphodiesterase inhibitor, confirmed that cAMP was the
common mediator of the three agents tested. The effect of
cAMP on APN was significant but of a much lower magnitude,
about one tenth of that obtained for APA at the greatest
concentrations of the three agents studied. Interestingly, trans-
formed glomerular epithclial cells responded to cAMP similarly
to their parental cells, This confirms that the transformed cell
line possesses the characteristics of the normal cells from which
it derives [14] and could thus represent an abundant and stable
material for their study. cAMP effect needed a lag time of 24
Table 5. Effect of inhibition of protein and RNA synthesis on
forskolin-induced aminopeptidase A activity in human glomerular
epithelial cells
400
4 300
(5
C
200
a,a
100
EC
0
Cells were preincubated with cycloheximide or actinomycin D for I
hour before addition of forskolin and were then incubated for a further
period of 72 hours. Data are means 5E of 4 determinations. Data were
analyzed using Student's i-test.
a P C 0.01 vs. control FK — + - + cAMP — + - +
Dex— — + + Dex — — + +
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hours and was maximum after 72 hours of incubation. It was
also inhibited by cycloheximide and actinomycin, confirming
that its mode of action involved protein synthesis. Such an
effect of cAMP on enzyme expression has been extensively
described in many systems including 5'-nucleotidase in rat
mesangial cells [32], ecto Ca2 ATPase in an hepatoma cell line
[33], and y glutamyl transpeptidase in LLC-PKI cells derived
from the pig renal proximal tubule [341. The relatively slow rate
of induction of transcription by cAMP and the sensitivity to
cycloheximide suggest that the gene of APA belongs to the slow
responding class of the cAMP-regulated genes [34]. It differs
from the genes of a variety of other enzymes whose transcrip-
tion depends on the rapid activation by the complex cAMP-
protein kinase of the cAMP regulatory element (CRE) binding
protein or the AP-2 element binding protein. The effect of
cAMP and dexamethasone were additive, suggesting that these
two agents do not act along the same pathway.
Polarized membrane expression of brush border hydrolases
in primary cultures of kidney proximal tubular cells depends on
cell differentiation. APN, neutral endoproteinase and dipepti-
dyl-peptidase IV were shown to be distributed essentially at the
surface of these cells after incubation with dexamethasone,
whereas they were abnormally concentrated in a cytoplasmic
vesicle compartment in the presence of serum or in the absence
of dexamethasone [35]. Since there is an intracellular pool of
APN and APA in glomerular epithelial cells, the results ob-
served in the present study could be attributed to the targeting
of a storage cytoplasmic pool of these enzymes to membrane
domains. This hypothesis is not likely because PMA for APN as
well as cAMP for APA stimulated both cell surface and total
cell activities.
The role of AYN and APA of glomerular epithelial cells is still
unknown. As many ectopeptidases in other tissues, they can
regulate autocrine and paracrine signals by proteolytic activa-
tion or inactivation of peptidic autacoids. They can also process
proproteins into their final active secreted forms. Such effects
have been already reported in various preparations. For exam-
ple, brain and lymphocyte APN were characterized as macti-
vators of enkephalines [36] and thymopentin [37], respectively.
APA transforms by deletion of the N terminal aspartic acid
angiotensin II into the less active 2-8 heptapeptide. It may thus
regulate the action of angiotensin IT in the glomerulus where
expression of a local renin-angiotensin system has been dem-
onstrated. APA expression is increased in the glomeruli of the
remnant renal tissue of partially nephrectomized rats, which
suggests this enzyme may play a role in glomerular adaptations
after renal mass ablation [38]. Both APA and APN may also be
involved in the final trimming associated with posttranslational
modifications of secreted proteins as suggested recently for
ectopeptidases in general [39].
The present study demonstrates that the control of APA and
APN activities in glomerular epithelial cells is different. This
selective expression may provide new insights regarding their
possible biological significance. Cell surface peptidases may act
as modulators of growth and differentiation. Local increases in
glomerular mediators such as thrombin which stimulates PKC
or PGE2 which stimulates cAMP and the protein kinase A
pathway are likely to modify aminopeptidase expression. This
could represent a supplementary mechanism whereby these
autacoids modify the glomerular functions in the course of
glomerular diseases.
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